INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/13/2020
Back to search
Official data from USPTO
HYBRIGENICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079063980Class
1, 5, 9, 35, 38, 42
Filing
79063980
Registration
3731611
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
11/13/2020
Trademark type
Combined
Nice classes
1, 5, 9, 35, 38, 42
Filing date
03/07/2008
Registration date
12/29/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/30/2020
Last transaction
01/30/2020
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
PARIS, FR
Examiner
BLANE, SUZANNE
Law office
M50
Mark description
The mark consists of the wording "HYBRIGENCIS" in stylized font.
Holders and representatives
Holders
HYBRIGENICS SA
HYBRIGENICS SA
Representatives
Jeannine A Rittenhouse IpHorgan Ltd.
Technical classification
Nice Classes
Class 1Class 5Class 9Class 35Class 38Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological materialsbiological reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays for scientific or medical research; proteins intended for producing protein for therapeutic useprotein arrays for scientific and medical research and therapeutic proteins for scientific use in drug discovery
Class 5
Pharmaceuticalspharmaceutical preparations for the prevention and treatment of disorders of the immune systemthe cardiovascular systemthe metabolic systemgenito-urinary systemthe musculo-skeletal systemdermatologic systemalimentary tractsensory organsparasitic diseasesfor the treatment of inflammatory disorders for use in dermatologyoncologyhematology and in tissue and organ transplantation and for gastrointestinal disorders; chemico-pharmaceutical preparationsfor use in treatment of viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; pharmaceutical products used in the treatment of viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; antibioticsbiologicalbiochemical and biotechnological preparations for medical purposeschemical preparations for pharmaceutical purposes for the treatment of neurologicalinflammatoryimmunologicaldermatologicalviralinfectious diseasesinfectionsparasitescancerneurodegenerative diseasesobesitydiabetes; reagents in the nature of cultures of microorganisms for medical use; surgical tissuessurgical implants comprising living tissue
Class 9
Computer programssoftware and software packagesall for the scientific analysis and research used in biologybio-computingbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomy; interface boards for computersapparatus for recordingtransmission and reproduction of sound; data processing and computer equipment in the nature of data processors and computersall the aforesaid goods being used in biologybio-computingbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomy
Class 35
Subscription services to databases in the nature of subscription to electronic journals; database managementprovision of computer databases; all the aforesaid services being used in biologybio-computingbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomy
Class 38
Telecommunicationstransmission of information via computer transmissiondigital networkselectronic communications networks; and the telecommunication networks; communications by computer terminals and by means of telecommunications in the nature of communication via analogue and digital computer terminals and by satellite; transmission of informationvia computer networks; communications and exchange of information on a telecommunications network; computer-assisted transmission of imagesdatamessages; providing multiple use access to global computer information networks for data dissemination over a telecommunications network; provision of access to databases by means of computer servers; communication by hypertext links over a telecommunications network and particularlythe Internet; providing e-mail services; data transmission servicesthe transmission of data into electronic directories and information transmission via telecommunications networksall the aforesaid services being used in biologybio-computingbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomy; information exchange services over a telecommunication networkinformation in the field of telecommunicationsradiotelegraphictelephonetelematic communicationsbroadcasting of information by the way of a database on the Internet in the pharmaceutical field; rental of access time to a database server; rental of access time to a computer for the handling of dataall these services being used in biologybioinformaticsbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomy
Class 42
Scientific and industrial research; the refinement of industrial processes and automationupdates of industrial process control; professional consultancy in the fields of industrial and scientific researchin biologybio-computingbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomymaterials testinglaboratories in the nature of chemicalbiological and medical laboratoriescomputer programmingall the aforesaid services being used in biologybio-computingbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomy; industrial and scientific research in the field of molecular biologyin genomicsproteomicsprotein screening and research of protein interactions
Publications
History of USPTO decisions and trademark events.
47 publications found
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/21/2020
INPC
INVALIDATION PROCESSED
10/21/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/30/2020
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/30/2020
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
01/30/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/29/2020
ES71
TEAS SECTION 71 RECEIVED
12/11/2019
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
12/29/2018
RNWL
INTERNATIONAL REGISTRATION RENEWED
04/05/2018
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
06/23/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/04/2017
XXCR
GENERIC MADRID TRANSACTION CREATED
03/04/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/28/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/28/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
01/28/2016
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
01/28/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/21/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
01/21/2016
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
01/21/2016
PR71
POST REGISTRATION ACTION MAILED - SEC.71
12/31/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/30/2015
ES71
TEAS SECTION 71 RECEIVED
11/18/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/18/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/26/2010
FIMP
FINAL DISPOSITION PROCESSED
04/26/2010
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/29/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
12/29/2009
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/13/2009
PUBO
PUBLISHED FOR OPPOSITION
10/13/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/10/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/25/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/25/2009
ALIE
ASSIGNED TO LIE
08/25/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/10/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/10/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/10/2009
RFNT
REFUSAL PROCESSED BY IB
03/06/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/11/2009
RFRR
REFUSAL PROCESSED BY MPU
02/11/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/11/2009
CNRT
NON-FINAL ACTION WRITTEN
02/10/2009
MAFR
APPLICATION FILING RECEIPT MAILED
02/03/2009
DOCK
ASSIGNED TO EXAMINER
01/30/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/30/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/29/2009
Continuous trademark protection
Get notified about every new filing that threatens HYBRIGENICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.